WEST PHARMACEUTICAL SERVICES, INC. EXTON, Pa., Jan. 5, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company's Board of Directors have approved a first-quarter 2022 dividend of $0.18 per share. The dividend will be paid on February 2, 2022, to shareholders of record as of January 19, 2022.
The Company's Board of Directors authorized a share repurchase program for calendar-year 2022 of up to 650,000 shares of the Company's common stock from time to time on the open market or in privately negotiated transactions, as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. The share repurchase program is expected to be completed by December 31, 2022. The Company's previously authorized share repurchase program expired on December 31, 2021.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.15 billion in sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-first-quarter-2022-dividend-and-2022-share-repurchase-program-301454933.html
SOURCE West Pharmaceutical Services, Inc.
